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Abstract
Mutations inGDAP1, which encodes protein located in the mitochondrial outer membrane,
cause axonal recessive (AR-CMT2), axonal dominant (CMT2K) and demyelinating reces-
sive (CMT4A) forms of Charcot-Marie-Tooth (CMT) neuropathy. Loss of function recessive
mutations inGDAP1 are associated with decreased mitochondrial fission activity, while
dominant mutations result in impairment of mitochondrial fusion with increased production
of reactive oxygen species and susceptibility to apoptotic stimuli. GDAP1 silencing in vitro
reduces Ca2+ inflow through store-operated Ca2+ entry (SOCE) upon mobilization of endo-
plasmic reticulum (ER) Ca2+, likely in association with an abnormal distribution of the mito-
chondrial network. To investigate the functional consequences of lack of GDAP1 in vivo, we
generated aGdap1 knockout mouse. The affected animals presented abnormal motor be-
havior starting at the age of 3 months. Electrophysiological and biochemical studies con-
firmed the axonal nature of the neuropathy whereas histopathological studies over time
showed progressive loss of motor neurons (MNs) in the anterior horn of the spinal cord and
defects in neuromuscular junctions. Analyses of cultured embryonic MNs and adult dorsal
root ganglia neurons from affected animals demonstrated large and defective mitochondria,
changes in the ER cisternae, reduced acetylation of cytoskeletal α-tubulin and increased
autophagy vesicles. Importantly, MNs showed reduced cytosolic calcium and SOCE re-
sponse. The development and characterization of theGDAP1 neuropathy mice model thus
revealed that some of the pathophysiological changes present in axonal recessive form of
theGDAP1-related CMT might be the consequence of changes in the mitochondrial
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Author Summary
Charcot-Marie-Tooth (CMT) disease is an inherited motor and sensory peripheral neu-
ropathy. Mutations in the GDAP1 gene cause either an axonapathy or an myelinopathy
that can be transmitted recessively or dominantly to offspring. GDAP1 is located in the
mitochondrial outer membrane and seems to participate in the mitochondrial network dy-
namics. To investigate the biological and functional consequences of lack of GDAP1 and
to gain insight into the pathophysiology of the GDAP1-related neuropathies we have gen-
erated a Gdap1 knockout mouse. Characterization of this model revealed that the absence
of GDAP1 induces a peripheral neuropathy with loss of motor neurons and abnormal
neuromuscular junctions. We also observed defects in embryonic motor neurons and
adult dorsal root ganglia sensory neurons derived from affected animals. Specifically, cul-
tured motor neurons showed large and abnormal mitochondria, dilated perinuclear space
and endoplasmic reticulum, changes in acetylation of cytoskeletal α-tubulin and calcium
depletion. We propose that pathophysiology of GDAP1-associated recessive CMT neurop-
athy may be the consequence of abnormal calcium homeostasis and changes in the mito-
chondrial network biology and mitochondria–endoplasmic reticulum interactions. Our
findings may be also relevant to understand the role of GDAP1 in relation to other neu-
ropathy-related mitochondrial proteins such as mitofusin 2.
Introduction
Charcot-Marie-Tooth (CMT) disease is one of the most frequent inherited neurological disor-
ders and is characterized by either demyelinating or axonal neuropathy of motor and sensory
peripheral nerves [1–3]. More than eighty genes are related to the pathogenesis of CMT and
other peripheral neuropathies affecting a wide number of biological functions and cellular
pathways [4,5] (http://neuromuscular.wustl.edu/time/hmsn.html). Mutations in GDAP1,
which maps at human chromosome 8q21.1, are causative for several types of neuropathy and
are transmitted through various modes of inheritance including autosomal recessive demyelin-
ating CMT4A with reduced nerve condition velocities (NCVs) [6], autosomal recessive axonal
AR-CMT2K with preserved NCVs and abnormal compound motor action potentials
(CMAPs) [7], and the less frequent autosomal dominant CMT2K [8,9] and recessive interme-
diate RI-CMT [10].
GDAP1 is a protein of 358 amino acids located at the mitochondrial outer membrane
(MOM) [11,12] and has two glutation S-transferase (GST) domains, with a protein interacting
α4-α5 loop domain between the two GST domains, and one transmembrane C-terminal do-
main that is important for the correct anchoring of the protein to the MOM [13]. GDAP1 is
mainly expressed in neurons [14] but expression in Schwann cells has also been reported [11].
GDAP1 plays a role in the regulation of mitochondrial dynamics inducing organelle fission
[11,12]. Whereas loss of function recessive mutations are associated with decreased fission ac-
tivity, dominant mutations result in impairment of mitochondrial fusion with increased pro-
duction of reactive oxygen species (ROS) and susceptibility to apoptotic stimuli [15]. Through
characterization of fibroblasts derived from CMT4A patients, Noack and colleagues [16]
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observed that GDAP1 is implicated in the control of the cellular glutathione content and mito-
chondrial activity, supporting the role of GDAP1 in the defense against oxidative stress. We
have recently demonstrated that GDAP1 silencing in the neuroblastoma SH-SY5Y cells reduces
Ca2+ inflow through store-operated Ca2+ entry (SOCE) upon mobilization of endoplasmic re-
ticulum (ER) Ca2+, likely in association with the abnormal distribution of the mitochondrial
network [17]. Thus, the pathophysiology of GDAP1-related neuropathies may involve complex
cellular interactions between mitochondrial network and ER, oxidative stress and Ca2+ homeo-
stasis, associated with mitochondrial dynamics and distribution.
Both demyelinating [6,18] and axonal [7,19] lesions have been reported in the nerve biopsy
from GDAP1-related CMT patients. However, electrophysiological studies indicate that espe-
cially in the more severe patients the GDAP1mutations induce primary axonal neuropathy
with secondary demyelination [19,20]. Data of mitochondrial morphology in biopsy specimens
are scarce, but in those cases when biopsy data were presented no abnormalities were reported
[1,21].
To investigate the functional consequences of loss of GDAP1 function in vivo, we generated
a Gdap1 knockout mouse (Gdap1-/-). Here, we describe characterization of this model and re-
port that the Gdap1-/- mice display neuropathic behavior and symptoms closely similar to
those of AR-CMT2K patients. Detailed characterization of the generated in vivomodel allowed
us to propose a pathogenic mechanism of the disease that involves depletion of cellular calcium
associated with changes in the mitochondrial network.
Results
Generation ofGdap1-/- mice
To generate the Gdap1 knockout mice (Gdap1-/-) we deleted exon 1 of Gdap1 by homologous
recombination. This was achieved by using a targeting vector containing a self-excising loxP-
exon 1 Gdap1-FRT-PGK-NeoR-FRT-loxP cassette (Fig 1A), which allows to generate a recom-
bined locus by deletion of the selectable marker Neo. The targeting construct was
Fig 1. Generation ofGdap1-/-mice. (A) Schematic representation ofGdap1-/- targeting strategy. Diagram is not to scale. Hatched rectangles represent
Gdap1 exons 1 to 6, solid line represents mouse chromosome 1. FRT sites are represented by double triangles and loxP sites are right-faced triangles. (B)
GDAP1 protein expression was assessed by immunoblotting of selected tissue homogenates prepared from 2 months-old wild-type (WT),Gdap1+/- (+/-) and
Gdap1-/- (-/-) mice.
doi:10.1371/journal.pgen.1005115.g001
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electroporated into 129sv stem cells and 2 recombinant clones were identified by both PCR
and Southern blotting. Gdap1-/- mice were established by breeding heterozygous Gdap1+/flox
mice with CMV-Cre deleter mice leading to ubiquitous exon 1 deletion. Gdap1-/- mice are born
at expected Mendelian ratios, have normal life-span and are fertile. Western blot analysis of
neuronal and non-neuronal tissue lysates of Gdap1+/+ (WT), Gdap1+/- and Gdap1-/- littermates
mice confirmed the absence of GDAP1 protein (Fig 1B).
Gdap1-/- mice develop motor deficits
The severe recessive form of GDAP1-related CMT starts early in infancy or childhood with
weakness and wasting of the feet followed by involvement of the hands leading to pronounced
disability. Patients are usually wheelchair bound starting from the second decade of life. Thus,
we compared motor behavior between Gdap1-/- and WTmice at the early adult age. We ob-
served abnormal hind-limb clasping reflex in Gdap1-/- mice at the age of 3 months (Fig 2A,
upper panels). When observed during locomotion, most animals showed very low position of
the body and dragging tail indicating presence of motor deficits (Fig 2A, lower panels). Then
we tested motor and coordination behavior by rotarod test in several ages. In order to avoid
previous learning we used different animals for each time point. We detected significantly re-
duced latency to fall in 3 months-old mutant mice. The persistence of this motor behavior was
confirmed in older Gdap1-/- mice from 4 to 7 months of age but became more variable and
thus non-significant after 9 months of age (Fig 2B).
In order to further characterize motor phenotype of Gdap1-/- mice we analyzed their gait be-
havior at the age of 5 and 12 months (Fig 2C). At both time-points Gdap1-/- mice had shorter
stride length (p<0.05 at 5 months and p<0.01 at 12 months, Student’s t test) and at 12 months
we also detected more narrow gait angles (p<0.001, Student’s t test) (Fig 2D, upper panels). As
we observed everted paws in some mutant animals, we also analyzed the plantar print (Fig 2D,
lower panels). At the age of 12 months we detected significant decrease of toe spreading and an
increased extension of plantar length that suggest a defect on the plantar muscle strength. The
observed defects in motor behavior in mice lacking GDAP1 prompted us to further investigate
their electrophysiological properties along the sciatic nerve. Therefore, we measured com-
pound muscle action potential (CMAP) amplitude (Fig 2E) and the motor nerve conduction
velocity (MNCV) (Fig 2F). In line with the absence of detectable behavioral phenotype, we
were not able to detect any electrophysiological differences between Gdap1-/- and WT mice at
2-months of age. Interestingly, at 5-months Gdap1-/- mice showed a significant reduction of
CMAP amplitude obtained for distal (at the ankle) and proximal (at the hip) stimulation, in-
dicative for an axonal neuropathy (Fig 2E, p<0.05, Student’s t test). Concomitantly, at this age,
we observed a slight but significant reduction in MNCV for Gdap1-/- mice as compared to WT
mice (Fig 2F, p<0.05, Student’s t test). However, we did not measure CMAP and MNCV at
later time points to assess the persistence of this effect.
Slight reductions in MNCV can be associated with axonal neuropathies [19]. In GDAP1-
CMT patients, axonal neuropathy is associated with loss of axons in sural nerve biopsies
[19,22]. We therefore decided to further investigate the nerve morphology of sciatic nerves
from 5-months-old Gdap1-/- and age-matched WTmice, the age at which we detected
electrophysiological changes compatible with presence of axonopathy (Fig 2). Surprisingly, we
did not detect any significant reduction in the axonal number correlating with the observed re-
duction in CMAP amplitude in 5 months-old mice (S1A and S1B Fig). Distribution of axon
sizes in both proximal and distal sciatic nerves did not show any differences between Gdap1-/-
and WT mice (S1C Fig). Moreover, myelin thickness was preserved in 5-months old Gdap1-/-
mice as well. By measuring g-ratio (ratio of axon diameter versus fiber diameter) in proximal
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Fig 2. Behavioural testing and electrophysiological measurements onGdap1-/-mice. (A) Upper panel shows photographs of 3 months-old mice
suspended by its tail. WT mice show a characteristic response trying to escape by splaying its hind limbs away from the trunk of its body. In contrast, hind
limbs ofGdap1-/- mice are held tonically against its trunk in an abnormal dystonic posture. Lower panels display a low body position and a dragging tail
present inGdap1-/-mice as compared to age-matchedWTmice. (B)Motor coordination was assessed by rotarod test, (n = 10 for each genotype and at each
age group). (C) Representative hind limb walking patterns of 5 months-old WT andGdap1-/- mice where the stride length (SL) and stride angle (SA) have
been depicted. Footprints revealed thatGdap1-/-mice walk with an abnormal gait. The scheme of a hindpaw footprint indicating measured parameters (PL:
plantar length; TS: toe spreading) has been included. (D)Quantification of various parameters obtained from the gait analysis of WT (black columns) and
Gdap1-/- (grey columns) animals at 5 and 12 months of age. Upper graphs show stride length (left) and stride angle (right). Lower graphs show the
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and distal sciatic nerves of both Gdap1-/- and WTmice we confirmed the presence of normal
myelin sheath with no myelination defects or myelin reduction associated with GDAP1 defec-
tive nerves (S1D Fig).
Lack of GDAP1 leads to loss of motor neurons and abnormal
neuromuscular junctions
Axonal neuropathy revealed by our electrophysiological studies in 5-months-old Gdap1-/- mice
could be associated with defects in other motor neuron-derived structures affected by the ab-
sence of GDAP1. Thus, we examined motor neuron (MN) numbers and morphology in the an-
terior horn, as well as the neuromuscular junction (NMJ) structure in Gdap1-/- mice at
different ages. MNs in the anterior horn showed cell lesions such as vacuoles and chromatolysis
in Gdap1-/- mice at 5 and 12 months of age (Fig 3A). We found statistically significant differ-
ence in the number of healthy MNs between knockout and control mice at 5 and 12 months of
age. However, while in control mice the number of healthy MNs per section underwent a pro-
gressive reduction over time (2-months vs 12-months WT animals, p-value<0.05), this process
is enhanced in Gdap1-/- mice as indicated by the slopes of neuron loss between 2 and 5-months
(Gdap1-/-: 0.71 versus WT: 0.333). By contrast, slopes were equal between 5 and 12-months,
which suggest that loss of neurons occurs early in the first months of life in the Gdap1-null
mice (Fig 3B). These data suggest that MN degeneration in the anterior horn may contribute to
the abnormalities revealed by CMAP measurements in 5-months Gdap1-/- mice.
Effects of pathological and functional changes in CMT diseases are related to the axonal
length, so distal limb muscles are usually the first to be affected. This is the case for patients
with GDAP1mutations, especially those carrying two recessive mutated alleles [23]. Thus, we
investigated the proper occupancy and morphology of NMJs in both Gdap1-/- and control
mice by staining axonal presynaptic buttons with an antibody against β-III tubulin and the nic-
otinic acetylcholine receptor with α-bungarotoxin. Occupancy of the NMJs was defined as the
percentage of postsynaptic buttons that are completely filled by the nerve terminal (Fig 3C).
We did not observe any differences in the NMJ occupancy at 5-months. However, whereas
NMJs from 12-month-old control mice were fully occupied the percentage of occupancy in the
NMJs from Gdap1-/- was significantly reduced (Fig 3D). In addition, we also observed abnor-
mal tangle-like structures in terminal nerves from knockout animals that were not present in
control mice (Fig 3E).
Cellular changes inGdap1-/- mice neurons
We decided to further investigate the consequences of the absence of GDAP1 in primary neuro-
nal cultures. After being cultured for 24 hours,Gdap1-null DRG sensory neurons from 5-months
old mice were able to generate neurites but we observed a significant reduction of neurite average
length in sensory neurons of Gdap1-/- animals (Fig 4A) and in general longer processes inWT
versus Gdap1-/- mice (Fig 4B). Embryonic MN cultures derived from both genotypes had similar
capacity to generate axons at 24 hours (length between 200 and 250 μm). However, at 48 hours
we observed substantial difference between the two genotypes (Fig 4C): whereas axons in cul-
tures generated from the knockout mice have maximal length of around 250 μm, axons from
wild-type mice showed continuous growth, some of them reaching 600 μm.
quantitative analysis of the hindpaw footprint parameters toe spreading (left) and plantar length (right). Analysis was conducted on 10 clearly visible footprints
at 5 animals per genotype. Determination of sciatic nerve compoundmuscle action potential (CMAP) amplitudes at both distal and proximal (E) as well as
motor nerve conduction velocities (MNCV) (F)measured in WT andGdap1-/- mice at 2 and 5 months of age (n = 4). Error bars indicate standard error of the
mean (S.E.M.). p values were calculated using Student's t test,*p<0.05, **p<0.001, ***p<0.0001.
doi:10.1371/journal.pgen.1005115.g002
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We have previously demonstrated that GDAP1 interacts with vesicle transport proteins
RAB6B and caytaxin, and with β-III tubulin [17,24]. Interaction with β-III tubulin prompted
us to investigate the effect of GDAP1 absence on the cytoskeleton of mouse MNs and DRG
neurons. Microtubules (MTs) are dynamically assembled polymers of α- and β-tubulin that are
present in all eukaryotic cells. Post-translational modifications (PTMs) that occur on MT are
crucial in order to maintain their dynamic stability. Many different PTMs have been reported
to occur on tubulin [25]. Among them, tubulin acetylation has been widely related to neurode-
generative diseases [26], in particular with CMT [27]. Thus, we analyzed lysine-ε-acetylation
of α-tubulin in a 24-hr cell culture system. We observed abnormal PTM of microtubules: α-tu-
bulin showed significant decreased acetylation in both neurites of sensory neurons (Fig 5A)
and MN axons (Fig 5B). These findings suggested a defect of the cytoskeleton associated with
the absence of GDAP1 in mitochondria.
Fig 3. Lack of GDAP1 leads to loss of motor neurons and abnormal neuromuscular junctions. (A) Anterior horns from lumbar spinal cord of 5 and
12-months-old mice were stained by Nissl staining. Reduced number of MNs and evidence of chromatolysis are visible inGdap1-/-mice. (B) Progressive
graphics representing the number of healthy motor neurons in anterior horns per section inWT (black line) andGdap1-/- (gray line) mice at several ages (n = 3).
(C)Representative confocal stack images of NMJs from the gastrocnemius muscle. Axons were immunostained with anti-β-III tubulin (β-III tub, green) and the
postsynaptic acetyl-choline receptor was stained with AF488-coupled α-bungarotoxin (BTX, red). (D)Histograms show the percentage of NMJ occupancy by
terminal axons inWT (black bars) andGdap1-/- (gray bars) mice. (E)Magnification of tangle-like abnormal structures (white arrows) at the terminal axons closed
to the NMJ observed inGdap1-/-micemuscles. * represents significant differences betweenWT andGdap1-/-mice;& indicates differences between ages of
WTmice; and # indicates differences between ages ofGdap1-/- animals (Student’s t test, data are presented asmeans ±S.E.M.).
doi:10.1371/journal.pgen.1005115.g003
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To get more information about the effect of loss of GDAP1 in the cell biology of neurons we
investigated the cell and organelle ultrastructure in 24-hr cell cultures of both WT (Fig 6A) and
knockout MNs (Fig 6B–6D). For both genotypes our cultured MNs showed neurites and puta-
tive axonal prolongations. Control MNs showed irregular and invaginated nuclei, reduced ER
cisternae, large number of free ribosomes, well-defined microtubules network, and polarized
mitochondrial distribution (Fig 6A). In MNs from Gdap1-/- mice we could distinguish abnor-
mal organelles structures with two major patterns that may be interpreted as consecutive steps
of the same pathological process: (i) neurons with dispersed round or spheroid mitochondria
and apparent increase of mitochondrial metabolism, enlargement and dilatation of the nuclear
envelope and perinuclear space, and significant increase number of small and medium-sized
vacuoles that may correspond to dilated ER cisternae (Fig 6B); (ii) more severely affected neu-
rons with large and tubular mitochondria with swollen cristae that are oriented along the longi-
tudinal axis, very large vacuoles with invaginations that are originated from the nuclear
envelope and from the small-medium vacuoles, phagolysosomes, and some autophagosomes;
it seems that ER cisternae are more compacted with reduced internal light (Fig 6C and 6D).
These observations suggest progressive cell pathology associated with the lack of GDAP1 in
motor neurons. Then, we characterized in detail morphological parameters from more than
Fig 4. Characterization of primary sensory andmotor neuron cultures fromGdap1-/-mice. (A)
Histogram representing significant differences of the neurites average length fromWT (black bar) and
Gdap1-/- (gray bar) mice (graph represents means and S.E.M of 3 independent culture preparation per
genotype. Student´s test **p<0.01) and (B) cumulative distribution of each neurite length from DRG sensory
neurons cultured for 24 hours from 5-months old WT (black solid line) andGdap1-/- (dotted gray line) mice
which are significantly different (p<0.001, Kolmogorov–Smirnov test). (C) Cumulative distribution of axonal
length from embryonic MNs cultured for 24 hours (left graph) and 48 hours (right graph) fromWT (black solid
line) andGdap1-/- (dotted gray line) mice. The two plots are not significant different (p>0.05; Kolmogorov–
Smirnov test. n = 195 axons from three independent experiments).
doi:10.1371/journal.pgen.1005115.g004
Pathomechanisms in theGdap1-/-Mouse Neuropathy
PLOS Genetics | DOI:10.1371/journal.pgen.1005115 April 10, 2015 8 / 27
900 WT and Gdap1-null mitochondria (Table 1). There were no differences in the number of
mitochondria per cell, surface area and perimeter of mitochondria between both genotypes.
Further analysis of mitochondrial shape parameters indicated that whereas Feret diameter and
roundness showed no differences, there were significant reduction of circularity and increase
of aspect ratio in Gdap1-null mitochondria. It seems that the absence of GDAP1 induces larger
mitochondria that may represent the increase of fusion activity of the mitochondrial network.
Mitochondrial defects induced by loss of GDAP1 function
Since GDAP1mutations have been associated with changes in the dynamics of the mitochon-
drial network and we detected morphological changes in mitochondria from somas of Gdap1-/-
MNs (Fig 6) we decided to characterize mitochondrial phenotype further. We investigated mi-
tochondrial parameters in both proximal (first 10 μm after neuron body) and distal (last
Fig 5. Postranscriptional modification of the tubulin cytoskeleton in primary sensory andmotor neuron cultures. (A) DRG sensory neurons and (B)
embryonic MNs were double-stained for acetylated α-tubulin (acetylated α-tub, green) and β-III tubulin (β-III tub, red). As indicated by respective histograms
there is a significant reduction of acetylated α-tubulin in both MN and sensory neurites inGdap1-/-mice. Graph represents means and S.E.M of 3
independent culture preparation per genotype. Student’s t test ***p<0.001.
doi:10.1371/journal.pgen.1005115.g005
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10 μm) segments of MN axons cultured for both 24 hours and 48 hours by detecting mitochon-
dria as cytochrome c positive organelles (Fig 7A and 7B). At 24 hours WT mice showed ho-
mogenous distribution in proximal and distal axonal segments. On the contrary, in Gdap1-null
mice the number of mitochondria was significantly increased at 24 hours in the proximal seg-
ment (Fig 7A), which could be interpreted as a delay of mitochondrial distribution along the
axon in the absence of GDAP1. Mitochondrial distribution normalized after 48 hours in cul-
ture. In parallele, we observed a reduction of the mitochondrial interconnectivity that was evi-
dent in the proximal segment after 24 and 48 hours in culture and in the distal segment after
48 hours (Fig 7B). The increased number of mitochondria in the proximal segment at 24 hours
and reduction of organelles interconnectivity suggests an anomalous distribution of the mito-
chondrial network associated with the lack of GDAP1.
We then decided to validate these data in vivo, by analyzing the effect of GDAP1 absence on
the structure and number of mitochondria in the proximal and distal regions of sciatic nerve.
Fig 6. Ultrastructural analysis of embryonic motor neurons.WT (A) andGdap1-/- (B-D) cultured embryonic MNs are shown. Medium and right panels
show higher magnifications of frames of whole cell in left panels. N: nucleus; M: mitochondria; PS: perinuclear space; LD: lipid droplet; AV: autophagic
vacuole; *: autophagolysosome; #: dilated endoplasmatic reticulum cisternae; arrowheads: endoplasmatic reticulum.
doi:10.1371/journal.pgen.1005115.g006
Table 1. Detailed morphological parameters for WT and Gdap1-/- mitochondria in mousemotorneuron
primary culture.
Mean (SEM) P value
Number of mitochondria in 100 μm
WT 76 (6) 0.330
Gdap1-/- 69 (4)
Surface Area, μm2
WT 0.16 (0.01) 0.496
Gdap1-/- 0.16 (0.01)
Perimeter, μm
WT 1.60 (0.04) 0.180
Gdap1-/- 1.66 (0.03)
Feret's Diameter, μm
WT 0.58 (0.01) 0.230
Gdap1-/- 0.61 (0.01)
Circularity (0–1)
WT 0.77 (0.01) 0.005
Gdap1-/- 0.73 (0.01)**
Roundness (0–1)
WT 0.65 (0.01) 0.120
Gdap1-/- 0.61 (0.02)
Aspect Ratio
WT 1.67 (0.04) 0.011
Gdap1-/- 1.88 (0.07)*
Mitochondrial shape descriptors were measured in 20 WT and 30 Gdap1-/- motorneurons. Student’s t test
was performed for normal distributed parameters (number of mitochondria, circularity, roundness and
aspect ratio) and Mann-Whitney U test for those that were non-normal distributed (surface area, Feret´s
diameter and perimeter). See Fig 6 for a visual representation.
*p<0.05,
**p<0.01.
doi:10.1371/journal.pgen.1005115.t001
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Fig 7. Mitochondrial quantitation and network distribution in cultured MNs and sciatic nerves fromWT andGdap1-/-mice.Number of mitochondria
(A) and network interconnectivity (B) in cultured MNs are represented. The study was performed in the proximal segments (p) and distal segments (d) of WT
(black bars) andGdap1-/- (gray bars) axons after 24 hour and 48 hour of cell culture. Error bars represent S.E.M. Student’s t test *p<0.05, **p<0.01 and
***p<0.001 (C) Left panel shows semi-thin cross sections of the sciatic nerve from five months old WT andGdap1-/- mice. Mitochondria are clearly visible on
higher magnification images of transversal section (right panel). Mitochondrial axonal content was quantified by electron microscopy on proximal and distal
cross sections of the sciatic nerve. (n = 4; Error bars represent S.E.M.; asterisks indicate significant differences betweenWT andGdap1-/-mice, Mann-
Whitney test, **p<0.01,***p<0.001). (D)Measurement of mitochondrial DNA (mtDNA) copy number in sciatic nerves.
doi:10.1371/journal.pgen.1005115.g007
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Whereas mitochondrial morphology was unaffected in Gdap1-/- nerves, the number of mito-
chondrial particles was significantly increased both proximally and distally (Fig 7C). To know
whether such an apparent increase could represent a true increase of the number of mitochon-
dria or may reflect the increase of the mitochondrial mass we determined the number of
mtDNA copies in sciatic nerves. We did not detect any significant difference on the mtDNA
copy number, and hence mitochondrial mass, between Gdap1-/- and WT nerves (Fig 7D).
Motor and sensory neuropathies are frequently a consequence of mitochondrial defects as-
sociated with changes in mitochondrial respiratory chain and oxidative phosphorylation, that
affect the energetic metabolism of peripheral nerves. To evaluate if similar type of changes are
present in Gdap1-/- animals. we performed protein expression analysis on selected mitochon-
drial proteins at the age of 5 months. Extracts from skin, skeletal muscle, liver, brain, cerebel-
lum, spinal cord and peripheral nerves were prepared and printed onto Reverse Phase Protein
Microarrays (RPPM) to quantify the expression of relevant enzymes of glycolysis (GAPDH,
PKM2, LDHA), oxidative phosphorylation [OXPHOS, Complex I (NDUFS3), Complex II
(SDHB), Complex III (Core 2), Complex IV (COXI, COXII and COXIV) and Complex V (β-
F1-ATPase)], mitochondrial dynamics (MFN1 and MFN2), β-oxidation of fatty acids
(HADHA), oxidative stress (SOD2 and catalase) and the cytoskeleton (β-actin, used as loading
control) using validated antibodies (S2 Fig). For most of the analyzed tissues (liver, skeletal
muscle, brain, skin, and spinal cord) no relevant differences were observed in the expression of
the proteins studied (Fig 8A,). Interestingly, cerebellum, involved in balance and motor behav-
ior, and especially peripheral nerves (sciatic and axillary nerves) showed significant differences
in protein expression (Fig 8B and 8C). Specifically, the cerebellum of Gdap1-/- mice revealed a
diminished expression of several enzymes of glycolysis, OXPHOS and mitochondrial dynamics
when compared to WT mice, suggesting a limited energy provision in this tissue (Fig 8B). Even
more significant changes were observed in expression of all markers of glycolysis, OXPHOS
and mitochondrial dynamics as well as catalase of oxidative stress but not HADHA of β-oxida-
tion in peripheral nerves of Gdap1-/- mice when compared to WT mice (Fig 8C), which were
confirmed by Western blot experiments in nerves (S3 Fig). This strongly suggests that a bioe-
nergetic compromise, because of dysfunctional mitochondria, may contribute to a dysfunction
of peripheral nerves and most likely cerebellum in Gdap1-/- mice. Intriguingly, differences on
peripheral nerves were more significant in females, which may be related to the animal hor-
mone environment.
Pathogenic effects of lack of GDAP1 involve Ca2+ signaling
In SH-SY5Y cells we have observed that GDAP1 depletion decreases SOCE activity and im-
pairs Ca2+ entry in mitochondria following activation of store-operated calcium entry [17].
This might be related to the altered distribution of the mitochondrial network within the cell
associated with abnormal movement of mitochondria along the cytoskeleton towards the ER
and subplasmalemmal microdomains in neuroblastoma cells having residual GDAP1 expres-
sion. With our knockout mouse model we are now able to analyze the consequences of a com-
plete lack of GDAP1 on Ca2+ levels in the cytoplasm in neurons and the effect on SOCE in
vivo.
We first studied cytoplasmic calcium ([Ca2+]cyt) transients triggered by emptying of ER-Ca
2+
with thapsigargin (TG) in a Ca2+-free medium and the effect of Ca2+ readmission on SOCE ac-
tivity in 24 hour-cultured motor neurons. Interestingly, neurons lacking GDAP1 showed signifi-
cant lower [Ca2+]cyt thanWT neurons before and after ER-Ca
2+ emptying with TG (Fig 9A).
BothWT and Gdap1-/- cells responded to 2 mMCa2+ by increasing [Ca2+]cyt, which suggest that
SOCEmechanism is working. However, SOCE response was smaller with lower [Ca2+]cyt peak
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Fig 8. Selectedmetabolic protein profiling of tissues fromGdap1-/-mice.Representative RPPM for each tissue (top) and histograms (bottom) show the
expression level of selected markers in various processes of the mitochondrial metabolism in skeletal muscle (A), cerebellum (B) and peripheral nerves
Pathomechanisms in theGdap1-/-Mouse Neuropathy
PLOS Genetics | DOI:10.1371/journal.pgen.1005115 April 10, 2015 14 / 27
inGdap1-/- neurons, which may reflect the reduction of Ca2+ in resting conditions (Fig 9B). In
addition, such reduced Ca2+ levels was also associated with slow entrance velocity of Ca2+ into
the neuron (Fig 9C). Low resting levels of [Ca2+]cyt and slow entry of Ca
2+ after store Ca2+ deple-
tion suggest that lack of GDAP1 induces a defect on the proper maintenance of intracellular Ca2+
concentration and homeostasis. To know if such a low cytoplasmic Ca2+ concentration may be
due to reduced calcium stores in cells, we treated motor neurons with ionomycin, a strong iono-
phore that releases calcium from cellular stores. Neurons defective for GDAP1 showed significant
lower increase of [Ca2+]cyt thanWT neurons, which might affect ER-Ca
2+ release or reduction of
Ca2+ stores (Fig 9D and 9E). These findings suggest that GDAP1 is necessary to maintain neuro-
nal Ca2+ homeostasis. To knowmore on Ca2+ management within the ER, we further investigate
the effect of lack of GDAP1 in the ER-Ca2+ physiology by measuring the calcium-handling pro-
teins calreticulin, IP3R and BIP in both mouse sciatic nerve and lumbar spinal cord (S4 Fig).
(sciatic and axillary) (C) of 5-monthsWT (white bars) andGdap1-/- (grey bars) mice (for printing details see S2B Fig). β-actin was used as loading control.
The expression level of the different proteins was expressed relative to that found in HCT116 colon cancer cells. The means (±S.E.M) are indicated. Asterisk
indicates significant differences betweenWT andGdap1-/-mice (n = 10, *p<0.05, Student’s t test).
doi:10.1371/journal.pgen.1005115.g008
Fig 9. SOCE alteration inGdap1-/- embryonic motor neurons (A) Fura-2 [Ca2+] signals of embryonic MNs fromWT (black) andGdap1-/- (grey) mice.
After Ca2+ release from cell stores with 5 μM thapsigargin (TG) treatment during 7 min in Ca2+ free medium, SOCE was activated by adding 2 mM of CaCl2.
Traces were used to obtain (B)maximumCa2+ peak during SOCE and (C) SOCE Ca2+ influx (slope). (D) Fura-2 recordings of 5 μM ionomycin elicited [Ca2
+]cyt peak in Ca
2+-free medium. (E)Maximum [Ca2+]cyt peak obtained in Ca
2+-free medium represents total amount of cytoplasmic Ca2+ after cell stores Ca2+
release. Traces were obtained averaging at least 100 cells from each genotype. Error bars represent S.E.M. (***p<0.001, Student’s t test).
doi:10.1371/journal.pgen.1005115.g009
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WhereasGdap1-/- mice did not showed any change of the expression levels of calreticulin and
BIP, the absence of GDAP1 induced upregulation of IP3R. This change was significant in the sci-
atic nerve at the age of 5 months and spinal cord at the age of 12 months. Such an upregulation
might be interpreted as a specific response to the [Ca2+]cyt depletion in MNs.
Discussion
Mitochondria have a pivotal role in the pathogenesis of neurodegeneration [28]. Besides the
classical role of defective oxidative phosphorylation in neurological disease there is increasing
evidence of the relevance of mitochondrial trafficking and transport, inter-organelle communi-
cation—especially with the ER—and mitochondrial dynamics and quality control [28,29]. Pe-
ripheral nerve pathologies are observed in mitochondrial disorders and vice versa CMT has
been associated with mutations in genes implicated in mitochondrial biology e.gMFN2 and
GDAP1 [1].
Mutations in the GDAP1 gene cause both demyelinating and axonal CMT neuropathies.
Most patients are homozygous or compound heterozygous for the mutation and express a se-
vere early-onset of autosomal recessive CMT4A [6,18] or AR-CMT2K [7,19] phenotypes re-
spectively. Yet milder axonal dominant variant (CMT2K) has also been reported [8,9,30],
which suggest different pathogenic consequences of the GDAP1 mutant protein and mecha-
nisms of the neuropathy. GDAP1 is mainly expressed in neurons [14], but expression in
Schwann cells has also been reported [11]. Thus, a major question regarding the pathophysiol-
ogy of GDAP1-related CMT is the primary injury target in the nerve, the axon or the Schwann
cell.
In order to gain insight into the cellular pathogenesis of GDAP1 defects and disease patho-
physiology we have generated and characterized a knockout mouse model of recessive forms
(CMT4A/2K) of GDAP1-related peripheral neuropathy. We observed multiple differences in
motor behavior of Gdap1-/- mice. Knockout animals showed significant reduced running time
on the rotarod starting at the age of 3 months, suggesting presence of defects in the balance
and motor coordination. This difference disappeared at later time-points (>9 months), likely
as a consequence of the onset of age-related coordination impairments at control mice or be-
cause of the compensatory effects in CNS of the Gdap1 gene paralogue Gdap1l1 (S5 Fig) [31].
Gait analysis also showed changes in the motor behavior in 5- and 12-months animals as mea-
sured by the plantar footprint including stride length and angle. Similar features, even having
earlier onset, have also been observed in mouse models of neurological disease involving motor
neurons such amyotrophic lateral sclerosis [32,33]. Thus, the observed motor behavior deficits
suggested that lack of GDAP1 leads to a peripheral neuropathy phenotype.
Reduced CMAPs amplitude in both distal and proximal nerve segments from 5-months-old
mice strongly suggested the axonal nature of the neuropathy. Unexpectedly, normal number of
axons and axon diameter distribution revealed no evidence of morphological axonopathy as
observed in patients [19,22,23] or signs of demyelination. However, physiological damages
were revealed by proteomic studies of the energetic metabolism in peripheral nerves. Limited
energy supply and reduction of mitochondrial mitofusins under the Gdap1-/- background fur-
ther suggested the existence of an axonal defect associated with mitochondrial abnormal func-
tion. Such functional-morphological contradictions may reflect specific response to the lack of
GDAP1 in mice that could be more subtle than in human beings or reflect differences between
both species related to diseased nerve length and/or natural history [23]. In contrast with the
unaltered morphology of nerves, Gdap1-/- mice showed evidence of pathological changes in
both motor neuron somas and the NMJs. This phenotype may be interpreted in two ways: (i)
changes in motor neurons might be either a compensatory response to the abnormal function
Pathomechanisms in theGdap1-/-Mouse Neuropathy
PLOS Genetics | DOI:10.1371/journal.pgen.1005115 April 10, 2015 16 / 27
of nerves that are not altered enough to show pathological changes, or lack of GDAP1 in mice
may be expressed primarily as a motor neuron disease; or (ii) both proximal lesions at neuronal
somas and distal changes at NMJs may be the consequence of mitochondrial dysfunction in
dendrites and distal synapsis where mitochondria are more present.
GDAP1 is located at the MOM and has originally been previously show to play a role in mi-
tochondrial dynamics [11,12,34]. The increase in mitochondrial density observed in both prox-
imal and distal axons of Gdap1-/- mice can be caused by various changes in mitochondrial
biology: alteration in mitochondrial fission-fusion balance, increase of the total mitochondrial
mass or mitochondrial transport defects. Since we observed that in sciatic nerves of Gdap1-/-
mice the total mitochondrial mass is not different between WT and knockout mice, we favor
the hypothesis of a defective mitochondrial dynamics. Interestingly, an increase in the number
of mitochondria in peripheral axons, especially in those with diameters smaller than 3.5 μm,
has also been observed inMfn2 transgenic mice which is a mitochondrial fusion-related pro-
tein that is also located in the MOM [35]. In addition, we also observed that the loss of GDAP1
is associated with lower interconnectivity of organelles found in primary culture of MNs, re-
duced axon growth capacity in both MNs and DRG sensory neurons, and a reduction of micro-
tubule acetylation. Together, defects in the maintenance of the mitochondrial network and
cytoskeleton along with abnormal energy metabolism might explain the electrophysiological
changes in axons with preservation of the nerve architecture.
More recent experimental data suggest a protective role of GDAP1 against oxidative stress
related to intracellular levels of glutathione [16,36]. Lopez Del Amo et al. have validated the
Drosophila GDAP1 ortholog (Gdap1) [36]. In this model, Gdap1 RNAi produces progressive
aggregation of the mitochondria, and eventually the presence of large elongated mitochondria
in the fly thorax muscle, and at the retina mitochondria have larger size and tend to lose their
peripheral localization. Moreover, we have shown that depletion of GDAP1 in the SH-SY5Y
cells decreases SOCE activity and impairs SOCE-driven Ca2+ uptake in mitochondria, which
may be linked to abnormal distribution of the mitochondria network [17]. In addition, GDAP1
is also present in mitochondrial-associated membranes (MAMs) [17] suggesting its function in
the interaction between mitochondria and ER as it has also been proposed for MFN2, the gene
mutated in CMT type 2A [37]. Thus, available experimental data indicate that GDAP1 may
link mitochondrial dynamics, ER and Ca2+ homeostasis regulation. In spite of these studies,
the function of GDAP1 is not well established yet. Most of the recessive mutations predict trun-
cated proteins with loss of the C-terminal domain that anchors GDAP1 to the MOM. Missense
mutations may not affect the proper protein location but rather impair mitochondrial fusion
and cause mitochondrial damage [15].
Our studies on Ca2+ homeostasis and SOCE activation in Gdap1-/- cultured MN showed re-
duced [Ca2+]cyt in both resting status and after pharmacological-mediated calcium depletion
with thapsigargin or ionomycin. These findings suggest that the low levels of [Ca2+]cyt associat-
ed with the lack of GDAP1 could represent partial depletion of cellular calcium stores and/or
release defects. Reduced Ca2+ stores and/or abnormal ER-Ca2+ release may impair proper
stored-operated Ca2+ influx as well, which in turn may affect Ca2+ signaling homeostasis.
These data in primary mouse MN and those we previously obtained in gene-silenced human
neuroblastoma cells [17,38] suggest that GDAP1 plays a relevant role on the [Ca2+]cyt mainte-
nance that can be, at least partially, mediated by SOCE. Thus, GDAP1 might mediate interac-
tions between mitochondria and ER by positioning the mitochondrial network properly. The
observation of large, dispersed and non-polarized mitochondria within cultured MNs in elec-
tronic microscopy experiments favors our hypothesis. Functional mitochondria are required to
maintain SOCE activity [31,39]. The absence of mitochondria close to the Ca2+ microdomains
may reduce the formation of SOCE channels between ER and plasmatic membrane and may
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reduce the Ca2+ entry operated by ER Ca2+ release. Calcium ions themselves control a wide
number of cellular functions underlying cell signaling events. Abnormal calcium signaling has
been associated with neurodegeneration [40] and increased [Ca2+] in the ER is observed in
neurodegenerative diseases [41] but the pathological effects of reduced [Ca2+] in the ER is a
less known phenomenon. Chronic depletion of cellular Ca2+, either in ER or cytosol or both, af-
fects the fluctuations and signaling of calcium ions and may induce pathological changes in mi-
tochondria and ER and their physiological interaction which in turn may lead to the unfolding
protein response (UPR) and activate the ER-stress-induced apoptosis pathway [42]. Difficulties
to maintain the Ca2+ concentrations in cellular compartments and the abnormal cellular re-
sponse may explain the progressive phenotype and neuropathology observed in our Gdap1-/-
mouse model.
Recently, Niemann et al. [43] reported an age-related hypomyelinating peripheral neuropa-
thy in a Gdap1 knockout mouse model generated by deletion of exon 5. These knockout mice
developed a late-onset neuropathy with reduced nerve conduction velocity and changes in the
nerve myelination. Morphometric studies revealed hypomyelination in 19-months-old knock-
out mice with no detectable axonal loss. In addition, sciatic nerve injury of knockout animals at
the age of 2 months led to a less effective remyelination as compared with WT animals. The au-
thors also found reduction in the CMAP amplitudes that may suggest an axonal component in
the neuropathology phenotype. In contrast, our Gdap1-/- mouse model expressed an earlier
onset in neuropathy-related signs as indicated by motor behavior abnormalities at the age of 3
months and electrophysiological changes in 5-months-old animals (S1 Table). Since the same
technological approach was used to generate knockout animals, the major genetic difference is
the ablation of exon 1 in our case versus exon 5. In both cases GDAP1 protein is absent on
western blot analyses. However, we do not have sufficient information about consequences on
transcription and RNA biology. These authors propose that mutations in Gdap1 lead to mild,
persistent oxidative stress in the peripheral nervous system, which may be compensated in the
central nervous system (CNS) by translocation of GDAP1L1 from the cytosol to mitochondria.
We have studied Gdap1l1 expression in our Gdap1-null mouse, but we did not observe differ-
ences in brain, spinal cord and DRG between WT and Gdap1-null mice. (S5 Fig, S1 Text).
However, the strong expression of Gdap1l1 in brain of Gdap1-null mice, as in WT animals,
may protect the brain structures from any pathological effect caused by the lack of GDAP1.
In conclusion, our data indicate that the lack of GDAP1 in mice lead to abnormalities of cal-
cium homeostasis and changes in the axonal and neuronal physiology of the mitochondrial
network and the ER. These results provide new insight into neuropathy caused by the loss of
function GDAP1mutations. The effects of GDAP1 recessive missense and dominant mutations
on calcium signaling and the interaction with mitochondria and ER require further studies.
Materials and Methods
Generation of theGdap1 knockout mouse model
Vector construction and targeted knockout strategy was designed together with genOway
(Lyon, France), where mice were generated. The genomic region of murine Gdap1 locus was
isolated from a 129Sv library/Pas, called rTgV, developed at genOway. The BAC clone collec-
tion rTgV was screened by PCR. The first pair of primers (sense: 5`-CAG GGG AAC ATA
ATC TGT GAG GAG GC-3 '; antisense: 5'-TCA CTA CTG GTG GTT CTT GTC AGC GC-3')
amplifies a genomic fragment 409 bp gene GDAP1 upstream of exon 1. The second pair of
primers (sense: 5'-GCG ACG GAA AAG CTC TAC CCT TAC C-3'; antisense: 5'-ACT GCA
GTA GCA CTT GAG TGG CAG G-3') amplified a pb 553 of exon 2 and intron 2 Gdap1 geno-
mic fragment. This molecular design led to the identification of a single BAC clone (# 2956A2),
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renamed clone FPA1-rTgV. DNA sequencing showed the Gdap1 homology regions of interest
in that specific clone, which was used subsequently to isolate both FPA1-Long arm (5.7 kb) as
FPA1-Short arm (1.8 kb) of target vectors. The target vector, FPA1-HR, contained two inserted
loxP sites flanking exon 1, the neomycin positive selection gene flanked by FRT sites and the
presence of diphtheria toxin A (DTA) as a negative selection marker. Robust PCR screening
strategy and Southern blot for detection of homologous recombination were designed. The
FPA1-HR 129SvPas construct was transfected into ES cells according to standard electropora-
tion procedures. Positive selection was started 48 h after electroporation, by adding 200 mg/ml
G418 (Life Technologies, Inc.). 179 resistant clones were isolated and amplified in 96-well
plates. ES cell clones were screened by PCR to verify homologous recombination at the 3 'end
of Gdap1 locus: sense 5'-GCC ACT CTC CAG ATG TTG AAA GGA G-3'; antisense 5'-TCA
CTA CTG GTG GTT CTT GTC AGC GC-3'. a product of approximately 2.1 kb was expected.
Of 179 clones tested, 3' homologous recombination was observed in 8 clones, which were veri-
fied by Southern blot analysis of 3' and 5' recombination events in Gdap1 locus. Two recombi-
nant clones were microinjected into C57BL/6 blastocysts, giving rise to five male chimeras with
significant contribution of ES cells (positive agouti color) were characterized. These male mice
were bred with C57BL/6 Flp deleter female mice in order to cause cleavage of the germline neo-
mycin selection cassette. Genotyping by PCR and Southern blot of pups derived from F1 breed-
ing allowed identification of 6 heterozigous Gdap1 floxed mice heterozygous (Gdap1+/flox). To
generate a germline deletion of exon 1 female mice Gdap1+/flox mated with male C57BL/6 ex-
pressing CMV-Cre recombinase. Such a breeding allowed us the generation of heterozygous
constitutive Gdap1 knock-out mice (Gdap1+/- mice). Heterozygotes were matched to obtain
homozygous Gdap1-l- and Gdap1+/+ littermate mice that were subsequently amplified by inter-
crossing for experimental work. All mice were maintained at 21 ± 2° C in cycles of 12 h light/
dark with food and water ad libitum.
Genotyping. Genotyping was performed on tail tip DNA extracted with Wizard SV Geno-
mic DNA purification System (Promega) according to the manufacturer’s instructions. PCR
was performed using Expand High Fidelity PCR System (Roche Diagnostics) using the follow-
ing primers: Forward: 5’-CCT TGT TTC TCA TCT ACT CCT ATT ATC CGT AGG-3’ and
Reverse: 5’-GGA ACC CCT TCT CTC ACT TTC CAG G-3’
Western blotting. Snap frozen on dry ice tissues were homogenized in lysis buffer (50mM
Tris HCl pH 7.4, 1.5 mMMgCl2, 5 mM EDTA, 1% Triton X-100, 50 mM NaF, 1mMNA2VO3)
containing protease inhibitors (Roche). Tissue lysates (30μg) were collected and resolved in so-
dium docecyl sulfate polyacrylamide gels and transferred onto polyvinylidene difluoride
Immobilon-P transfer membrane filters (Millipore, Billerica, MA, USA) using an Amersham
Biosciences (Piscataway, NJ, USA) semidry Trans-Blot according to the manufacturer's in-
structions. The membranes were blotted with rabbit anti-GDAP1 and rabbit anti-β-actin
(Sigma-Aldrich), rabbit anti-calreticulin, rabbit anti-β-tubulin, rabbit anti-BiP and rabbit-IP3
Receptor (Cell Signaling) antibodies. Blots were developed using the ECL Prime chemiluminis-
cent substrate (GE Healthcare Amersham).
Motor coordination behavior and electrophysiology
Rotarod test. Motor performance and balance were tested using an accelerating rotarod
(UGO Basile Accelerating Rotarod). Each mouse underwent for 4 days the same procedure.
The first 2 days were used to train the mice (five sessions of 1 min each, walking at 4 r.p.m.).
The test sessions were run on day 3 and 4. Each test day, 2 series of 3 trials with a 2 hours rest
period between the 2 series and a 15 min rest period between consecutive trials was performed.
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During the test the speed of the rotarod was accelerated from 4 to 40 r.p.m. over a 5 min period.
A different group of animals was used for each time point of the study.
Gait and footprint analyses. Mice crossed an illuminated alley, 70 cm length, 9 cm width,
and 6 cm height, before entering a dark box at the end. Their hindpaws were coated with non-
toxic water-soluble ink and the alley floor was covered with sheets of white paper. To obtain
clearly visible footprints, at least 3 trials were conducted. The footprints were then scanned and
analyzed with ImageJ software (NIH). Four variables were considered: print length (PL), which
is the distance from the heel to the third toe, toe spread (TS), which is the distance from the
first to the fifth toe, stride length (SL) as the distance between initial contacts of the same paw
in one complete stride and stride angle (SA) which is the angle between the lines connecting
the first toe of footpads from each side of the stride.
Motor nerve conduction velocity and compound muscle action potential. Animals were
anesthetized with a mixture of 10 mL/g Ketanarkon 100 (1 mg/mL; Streuli) and 0.1% Rompun
(Bayer) in phosphate buffered saline (PBS) and fixed in the prone position. Motor nerve con-
duction velocity (MNCV) and compound muscle actions potential recordings in sciatic nerve
were performed as described previously [44].
Histological features
Motor neuron counting. Mice were sacrificed by gentle cervical dislocation. The lumbar
region of the spinal cord (L1–L5) was processed for paraffin embedding. 300 serial cross sec-
tions (10 μm thickness) of the lumbar spinal cords were made (3000 μm or 3 mm total length),
among which every fifth section (50 sections examined per animal) was processed and Nissl-
stained, as reported previously [45]. All cells were counted within the ventral horn below an ar-
bitrary horizontal line drawn from the central canal. The sections were analyzed at a 40x mag-
nification in the anterior horn (either left or right) for the presence of all neurons in that
region. Morphological criteria were also employed, so that only large polygonal neurons in
which the nucleolus was clearly visible at high magnification were included in the counts.
Neuromuscular junctions analysis. Preparation of the gastrocnemius muscles for immu-
nohistochemistry was performed as described [46] with some modifications. Muscles were
stained with α-Bungarotoxin-tetrametylrhodamine (10 μg/ml, Sigma) in PBS for 20 min for
acetylcholine receptor (AChR) clusters. Rabbit anti-β-III tubulin (1:500, Sigma-Aldrich) in
blocking solution was applied overnight at RT. As secondary Alexa 488-conjugated polyclonal
anti-rabbit (1:100, Invitrogen) was diluted in the blocking solution and applied for 5 h at RT.
Neuromuscular endplates of Gdap1+/+ and Gdap-/- mice were analyzed with a Leica SP8 confo-
cal microscope for morphological analysis.
Sciatic nerves morphometric analysis. Sciatic nerves from Gdap1+/+ andGdap-/- 5 months-
old mice were dissected and processed as reported elsewhere [44].
Profiling of metabolic proteins inGdap1-/-mouse tissues
Preparation of tissue extracts. Five females and five males 5-months old Gdap1−/−mice
and the same number of age-matched wild type animals were sacrificed and tissues were col-
lected (brain, cerebellum, spinal cord, liver, skin, skeletal muscle, and sciatic and axillary
nerves). ~ 0.2 g of frozen tissue powder was extracted with 300 μl of 50 mM Tris/HCl, pH 8,
containing 100 mMNaCl, 1 mMDTT, 1% (v/v) Triton X100, 0.1% SDS, 0.4 mM EDTA and a
cocktail of protease (Roche) and phosphatase (Sigma-Aldrich) inhibitors. Tissue samples from
the mix of the two peripheral nerves (~10 mg) were extracted in 30 μl of the extraction buffer.
After protein extraction, samples were centrifuged (15,000 g) at 4°C for 30 min. The protein
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concentration in the supernatants was determined with the Bradford reagent (Bio-Rad Protein
Assay) using BSA as standard. Aliquots of the supernatants were stored at -80°C until used.
Printing and processing of Reverse Phase Protein Microarrays (RPPM). Samples from
mice biopsies were processed and diluted in PBS to a final protein concentration of 0.75 μg/μl
before printing. The RPPM analysis was performed as described elsewhere [47] and in S2 Fig.
Real-time polymerase chain reaction assay for mitochondrial DNA copy
number
Mitochondrial DNA copy number quantification was based on the mouse tissue-adapted
ND1/ND4-quantification method [48]. Briefly, we quantified the mitochondrial 16S gene,
starting at position mt2469. The following primer/probe combinations were used for real-time
PCR with LightCycler 480 Probes Master Mix (Roche). Custom primer sequence for 16S: for-
ward primer: 5' AAT GGT TCG TTT GTT CAA CGA TT 3', reverse primer: 5' AGA AAC
CGA CCT GGA TTG CTC 3', and probe: FAM-5' AAG TCC TAC GTG ATC TGA GTT 3'-
MGB (Roche). Genomic DNA of a nuclear housekeeping gene, ANG1 (Assay AppliedBiosys-
tems: Mm00833184_s1) was also quantified using the same amount of DNA input. Relative
mitochondrial DNA copy number was determined by comparing 16S gene to the nuclear en-
dogenous control gene, also normalized to genomic DNA from blood.
Dorsal root ganglia (DRG) neuron cultures
Wild-type and Gdap1-/- 5-month-old mice were sacrificed and their lumbar DRGs dissected
out and collected in L15 media. Ganglia were incubated with 0.2% collagenase (30 min at 4°C
and 1 h at 37°C; GIBCO) followed by 0.05% trypsin (30 min at 37°C; GIBCO) and 1% DNase
(5 min at RT; Sigma) treatments, and further dissociated by passing several times through a
Pasteur pipette. After washing in F-12 medium, cells were diluted in F-12 medium supple-
mented with 200 mM glutamine, 60 ng/ml progesterone, 16 μg/ml putrescine, 400 ng/ml
L-thyroxine, 38 ng/ml sodium selenite, and 340 ng/ml triiodothyronine, 35% Albumax II,
10 μg/ml penicillin, 10 μg/ml streptomycin and 25 μg/ml amphotericin B. Neurons were plated
at a density of 2000 cells/cm2 on 0.05% poly-DL-ornitine (overnight at room temperature;
Sigma-Aldrich) and 20 μg/ml laminin (4 h at 37°C; Sigma-Aldrich) precoated 13 mm glass cov-
erslips and maintained in culture at 37°C in a humidified incubator under 5% CO2. For immu-
nolabelings, DRG cultures on coverslips were fixed in 4% paraformaldehyde (PFA) in PBS for
20 min, followed by 3 rinses in PBS, and an incubation with 3% horse serum and 0.2% Triton
X-100 in PBS (blocking buffer) for 30 min at room temperature. Coverslips were then incubat-
ed for overnight at 4°C with monoclonal rabbit anti-β-III tubulin (1:1000; Sigma-Aldrich).
After several rinses in PBS, coverslips were incubated for 1 h at room temperature, with fluoro-
chrome-labeled secondary antibody alexa-488 (1:400; Sigma-Aldrich). Finally, coverslips were
rinsed with PBS again and mounted in DAPI-fluoromount G. For quantification of various pa-
rameters of neurite outgrowth, fluorescent images from a Leica microscope were taken, and
morphological measurements were performed using the plugin Neuron J from the ImageJ soft-
ware. A neurite was defined as a process that measures at least the length of one cell body and
stains positively for neurofilament protein. The length of the longest neurite from the cell body
to its distal end were traced and measured for each neuron in order to calculate the average
length (300 cells were measured at each of 3 independent experiments).
Embryonic motor neuron (MN) cultures
MN cultures were prepared from 13.5 embryonic day (E13.5) mouse spinal cord as described
previously [49–51], but with minor modifications. Briefly, mouse embryo spinal cords were
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dissected and the dorsal half removed. Ventral spinal cords were dissociated mechanically after
trypsin treatment (0.025% trypsin in HBSS), and collected afterwards under a 4% bovine
serum albumin cushion. The largest cells were isolated by centrifugation (10 min at 520 g)
using iodixanol density gradient purification. The collected cells were finally suspended in a
tube containing MN complete medium: Neurobasal (Life technologies) supplemented with
B27 (Life technologies), 2% horse serum, 1x glutamax (Life technologies), and a cocktail of re-
combinant neurotrofins: 1 ng/mL BDNF; 10 ng/mL GDNF, 10 ng/mL CNTF, and 10 ng/mL
HGF (PreProtech). 10 μMAraC (Sigma-Aldrich) was added to the culture medium to limit the
growth of non-neuronal cells. Isolated MNs were plated on poly-D-lysine/laminin-coated sur-
faces as described previously [52], and grown in a 5% CO2 incubator at 37°C. For long-term ex-
periments, media was changed every 2–3 days. Cultured MNs were clearly identified by
immunofluorescence using SMI-32 (Covance) and HB9 (Millipore) antibodies or by morpho-
logical criteria.
Mitochondrial morphology and distribution in MN cultures. Isolated MNs (2000 cells)
plated on glass coverslips were fixed 24 and 48 h after plating with freshly prepared 4% PFA for
20 min at 37°C. Cultures were first blocked with PBS containing 4% BSA, 0.5% Triton X-100
for 1h at RT. Subsequently, cultures were incubated for 1h with the following primary antibod-
ies: mouse anti-SMI-32, a non-phosphorylated neurofilament-H (Steinberger Monoclonals),
rabbit anti-β-III tubulin (Sigma-Aldrich), sheep anti-Hb9 (Abcam) and mouse anti-cyto-
chrome c (Abcam). Cells were then incubated with the secondary antibodies Alexa-488 and
Alexa-633 for 1h at RT and counterstained with dapi for nuclei visualization. Images were cap-
tured on the detector assembly of a DMI 6000 microscope equipped with a Leica-TSC-SP8
laser scanning confocal imaging system and with a 63x 1.4 oil immersion objective. For confo-
cal z-axis stacks, series of stack images (1024x1024) separated by 0.5 μm along the z-axis were
acquired to visualize mitochondria. 3D reconstructions of the stacks were performed with the
VolumeJ plugin of ImageJ (N.I.H., USA). Mitochondrial morphology analysis was performed
as previously described [53]. We evaluate the number of mitochondria and the interconnectivi-
ty index (area/perimeter ratio). To evaluate the mitochondrial distribution along the axons, im-
ages were taken at 0,75x magnification and the projections were analyzed in two separated
segments (proximal, 10 μm closer to the soma and distal, 10 μm from to the axonal cone). Axo-
nal length was determined with the NeuronJ plugin of ImageJ. Al least 50 cells were analyzed
in three independent experiments.
For Transmission Electron Microscopy (TEM) isolated embryonic MNs were seeded onto
poly-D-lysine/laminin-coated Lab-Tek chamber slides of 2 wells (Nalge Nunc International),
fixed after 24 h of culture in 2.5% glutaraldehyde for 1 h at 37°C and processed for TEM as pre-
viously reported by Voliani et al. [54]. Two non-overlapping regions (16.500 magnification)
containing numerous mitochondria were selected for each motorneuron. Mitochondrial shape
descriptors and size measurements were obtained using Image J (version 1.48a, National Insti-
tutes of Health, Bethesda, MD) by manually tracing only clearly discernible mitochondria on
TEMmicrographs [55]. Surface area (mitochondrial size) is reported in squared micrometers;
perimeter in micrometers; Feret’s diameter represents the longest distance (μm) between any
two points within a given mitochondrion; circularity [4 (surface area/perimeter2)] and round-
ness [4 (surface area)/ (major axis2)] are two-dimensional indexes of sphericity with values of
1 indicating perfect spheroids; and aspect ratio (AR) is computed as [(major axis)/(minor
axis)] and reflects the “length-to-width ratio”. Computed values were exported to Microsoft
Excel. Analysis was performed at least on 900 mitochondria per genotype from independent
culture preparations (n = 2WT and n = 4 Gdap1-/-).
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Quantitative microtubule composition in neuron cultures
For quantitative analyses, isolated neurons plated on glass coverslips were fixed 24 and 48 h
after plating with freshly prepared PHEM (60 mM PIPES, 25 mMHEPES, 5 mM EGTA, 1 mM
MgCl2, pH 7.4), 4% PFA for 20 min at 37°C, washed with PBS and then activated with NH4Cl
for 5 min. Cells were then blocked for 45 min at RT prior to the double-staining for mouse
anti-acetylated α-tubulin (Ac-tub) and rabbit anti-β-III tubulin (β-III tub)(Sigma-Aldrich).
The blocking solution consisted of 10% fetal bovine serum (FBS) and 0.1% Triton X-100 in
PBS. As secondary antibodies we used an anti-mouse-Alexa488 and an anti-rabbit-Alexa633.
Cells were finally counterstained with dapi for nuclei visualization and kept at 4°C for 48h
prior to image capture. For confocal z-axis stacks, stacks of 10 images separated by 0.2 μm
along the z-axis were acquired using the appropriate color channel on the detector assembly of
a DMI 6000 microscope equipped with a Leica-TSC-SP8 laser scanning confocal imaging sys-
tem and with an 63x 1.4 oil immersion objective. Z-stacks at each point were collapsed to maxi-
mum projections and 3D reconstruction and volume rendering of the stacks were performed
with the appropriate plugins of ImageJ (N.I.H., USA). The acetylated α-tubulin was measured
with ImageJ software using stacks (6 slides, 0.21 μm each one) with the maximum projection.
Results were expressed as the acetylated α-tubulin fluorescence intensity through the neurite
or axon.
Measurement of [Ca2+]cyt
Cytosolic Ca2+ imaging with Fura-2 was performed as described by [56]. MNs were isolated
from 13.5 days embryos from each genotype as described previously. Cells were plated onto
24 mm round coverslips and, after 24 h, loaded with Fura-2AM by incubation in 30 mMD-
glucose Ca2+-free HCSS with 5 μM Fura-2AM and 50 μM pluronic F.127 acid (Sigma-Aldrich),
for 30 min at 37°C, and rinsed with HCSS, 2 mM CaCl2, for 30 min. Regions of interest (ROIs)
were selected by morphology taking into account only motorneurons. Fluorescence (emission
510 nm) ratio of Ca2+-free (F380) to Ca2+-bound probe (F340) was analyzed using Metafluor
for Leica developed by Metamorph (Universal Imaging). Analysis of SOCE was done using a
standard protocol, depleting ER-Ca2+ using 5 μM of TG and inducing SOCE with 2 mM of
CaCl2. The analysis of total Ca
2+ content was carried out using 5 μM of Ionomycin (Sigma-Al-
drich) in Ca2+-free HCSS plus 1 mM EGTA. Each experiment was plotted and calibrated in
terms of [Ca2+].
Statistical analyses
Calculations and statistical analysis were performed using Excel (Microsoft Corporation, Red-
mond, WA), Statgraphic statistical software and Prism software (GraphPad Software, Inc., San
Diego, CA). The specific test applied in each case is indicated in the figure legend or the text.
Differences were considered statistically significant when p<0.05, with a confidence limit of
95%.
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Supporting Information
S1 Fig. Characterization of sciatic nerve morphology. (A) Semi-thin cross sections of sciatic
nerves from 5-months WT and Gdap1-/-mice. No differences between genotypes were found
analysing numbers of fibers in 2 and 5 months old mice (B). Similarly, at proximal and distal
sciatic nerves axon size distribution (C) and g-ratio (D) show no differences between 5 months
old control and Gdap1-/- mice.
(TIF)
S2 Fig. Validation of the antibodies used in the study (A) and printing scheme of RPPM
(B). (A) 20 μg of tissue extracts (brain, B; heart, H) were fractionated on 4M urea SDS-PAGE
gels, blotted against the indicated antibodies and processed for western blotting. Only antibod-
ies that recognize a single protein band of the expected molecular mass were used in the study.
The migration of molecular mass markers is indicated to the left. (B) Shows the details of the
scheme of printing of RPPM. One μl samples were spotted in duplicate. Yellow boxed: negative
controls of BSA; Green boxed: IgGs spotted as positive control of the secondary antibody used;
Blue boxed: standard curves of HCT116 cells; Red boxed: tissue samples. The upper and lower
red boxed samples correspond to different tissues. The blue plot illustrates the linear correla-
tion that exists between the fluorescence intensity (arbitrary units, a.u.) and the amount of pro-
tein in HCT116 cell lysates. Note the absence of signal in BSA samples (yellow) and the linear
increase response of the secondary antibody towards increasing content of spotted IgGs
(green). Protein concentrations in the biopsies were calculated according to the fluorescence
intensity obtained
(TIF)
S3 Fig. Western blots show the expression level of some of the proteins studied by RPPM.
25 μg of tissue extract from peripheral nerves (sciatic and axillar) of two wild type (WT1,
WT2) and two Gdap1-KO (KO1, KO2) 5-months mice were fractionated on SDS-PAGE gels,
blotted against the indicated antibodies and processed for western blotting. Note the significant
reduction in the expression of LDHA, COXII and MFN2, and the presence of changes in the
expression of the mitochondrial SOD2, consistent with the findings reported in RPPM (Fig 8).
Representative blot of citoeskeletal tubulin as loading control.
(TIF)
S4 Fig. Effect of GDAP1 absence at Gdap1-/- mice tissues.Western blot analyses of Calreticu-
lin, BIP and IP3R in sciatic nerve (A) and lumbar spinal cord (B) biopsies of WT and Gdap1-/--
mice. Histograms show normalized intensities measured by densitometry and calculated
relative to β-actin. A representative blot is shown below each graph. Error bars are SEM. p val-
ues were calculated using Student's t test (n = 6. p<0.05).
(TIF)
S5 Fig. Ablation of Gdap1 does not change Gdap1l1 expression. Expression pattern of
Gdap1 paralogue gene Gdap1l1 by semi-quantitative reverse transcriptase PCR. No differences
were observed between WT and Gdap1-/- mice tissues.
(TIF)
S1 Table. Genetic and phenotype comparative analysis between Gdap1 knockout mice from
our study and Niemann et al.
(DOCX)
S1 Text. Supplementary Materials and Methods.
(DOCX)
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